Warmblood horses with mild, previously unrecognised insulin
dysregulation may already have subtle changes in heart structure and function,
even in the absence of obvious signs of heart disease, laminitis or other
metabolic problems.
Recent research findings suggest that insulin
dysregulation, best known for its association with laminitis and equine
metabolic syndrome, could have wider effects throughout the body than
previously recognised.
The study, published in the Journal of Veterinary
Internal Medicine, examined whether horses with subclinical insulin
dysregulation showed evidence of cardiovascular changes before developing
clinical disease.
Megan Palmisano and colleagues at the University of
Pennsylvania's New Bolton Center carried out a blinded cross-sectional study
involving 19 client-owned Warmblood horses aged between five and 15 years. All
had been referred for elective procedures and had no reported history of
cardiac disease, laminitis or metabolic disorders.
The horses underwent an oral sugar test to assess insulin
regulation. Eight were classified as insulin-dysregulated, while the remaining
11 had normal insulin responses. Researchers also assessed body condition
score, cresty neck score, blood pressure, metabolic hormone concentrations and
heart structure and function using echocardiography.
As part of the metabolic assessment, the team measured
leptin and adiponectin, hormones produced by fat tissue that play important
roles in metabolic health. They also used two-dimensional speckle-tracking
echocardiography, an advanced imaging technique capable of detecting subtle
changes in heart muscle function that may not be apparent with conventional
cardiac measurements.
Compared with healthy horses, those with insulin
dysregulation had larger left ventricular internal diameters and thicker
interventricular septa, changes consistent with early cardiac remodelling or
hypertrophy. At end diastole, the average left ventricular internal diameter
measured 11.77 cm in insulin-dysregulated horses, compared with 11.10 cm in
controls. Septal thickness averaged 3.10 cm versus 2.46 cm, while estimated
left ventricular mass was approximately 3,849 g compared with 2,898 g.
The insulin-dysregulated horses also showed significantly
lower radial strain, a measure of how the heart muscle deforms as it contracts.
Average radial strain was about 49%, compared with 67% in the control group.
Although conventional echocardiographic measurements generally remained within
established reference ranges, these more sensitive techniques revealed subtle
differences in heart muscle performance before any clinical signs were apparent.
High blood pressure did not appear to explain the findings.
Only two horses were classified as hypertensive, one in each group. This
suggests that metabolic or hormonal factors associated with insulin
dysregulation may contribute directly to cardiac remodelling, although the
study was not designed to determine the underlying mechanisms.
In people, insulin resistance and metabolic syndrome are
well recognised risk factors for left ventricular hypertrophy and
cardiovascular disease. Several mechanisms have been proposed, including
altered insulin signalling, chronic inflammation and metabolic stress. Whether
similar processes occur in horses remains uncertain. Importantly, this study
demonstrated an association rather than proving that insulin dysregulation
causes heart disease.
The authors conclude that horses with mild insulin
dysregulation show evidence of left ventricular remodelling consistent with
hypertrophy and suggest that cardiovascular changes could become part of the
broader clinical picture of insulin dysregulation.
The study has several limitations. It involved only 19
horses, all of them Warmbloods, so the findings may not apply to ponies, other
breeds or horses with more severe insulin dysregulation. Because the research
was cross-sectional, with measurements taken at a single point in time, it
cannot determine whether insulin abnormalities led to the cardiac changes or
whether another factor contributed to both.
Nor do the findings mean that every horse with insulin
dysregulation has clinically significant heart disease or requires
echocardiographic screening. The long-term importance of these subtle changes
remains unknown. Larger, long-term studies will be needed to establish whether
the cardiac changes progress, remain stable or improve with management of
insulin dysregulation, and whether they have implications for athletic
performance or increase the risk of arrhythmias or heart failure.
For now, the study adds to growing evidence that insulin
dysregulation may affect more than the feet, highlighting the need to consider
its potential impact on cardiovascular health as well as laminitis risk.
For more details, see:
Megan G Palmisano, Claire Underwood, Jeaneen Sage, Darko
Stefanovski, Andrew van Eps, JoAnn Slack.
Echocardiographic characteristics and evidence of
ventricular remodeling in subclinical insulin-dysregulated Warmblood horses
Journal of Veterinary Internal Medicine, (2026) Vol 40, (5),
aalag229.
https://doi.org/10.1093/jvimsj/aalag229